Cepheid GeneXpert consumables funding increased
Trusted by teams at
Description
Harris Health will ratify a $523,390 funding increase to its sole source agreement with Cepheid for GeneXpert reagents, test cartridges, and consumables from April 18, 2025 through April 17, 2026. The adjustment supports higher testing volumes.
Contract Details
Contract Amount
$523,390
Vendor
CEPHEID
Agency
Harris Health, TX
Contract Type
SUPPLIES
Document Date
May 13, 2026
Contract Term
April 18, 2025 through April 17, 2026
Renewal Date
2026-04-17
Renewal Info
Sole source consumables contract in effect through April 17, 2026; future renewal terms are not specified in the agenda.
More from CEPHEID
More from Harris Health
Harris Health Board of Trustees Board Meeting Agenda Packet 2026-06-10
Harris Health Board of Trustees Board Meeting Agenda Packet 2026-06-10
Harris Health Board of Trustees Board Meeting Agenda Packet 2026-06-10
Harris Health Board of Trustees Board Meeting Agenda Packet 2026-06-10
Harris Health Board of Trustees Board Meeting Agenda Packet 2026-06-10
Get alerts on contract renewals, new awards, and vendor activity.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.